Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
Nerdy Inc. (NRDY) Stock Analysis: Exploring a Strategic Opportunity with 28% Upside Potential 10 July 2025
Viant Technology Inc. (DSP) Stock Analysis: Insights into a Potential 53% Upside for Tech Investors 10 July 2025
Cytek Biosciences (CTKB) Stock Analysis: 60% Potential Upside Amid Healthcare Innovations 10 July 2025
Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings and 16% Potential Upside 10 July 2025
Pacific Biosciences of California (PACB) Stock Analysis: Is the 38.85% Potential Upside Worth the Risk? 10 July 2025
Alpha Tau Medical Ltd. (DRTS): Investor Outlook Reveals 168% Potential Upside with Promising Oncology Innovations 10 July 2025
Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Innovator Positioned for Growth Amidst Clinical Advances 10 July 2025
Aurora Cannabis Inc. (ACB): Investor Outlook Highlights Revenue Growth and Analyst Ratings 10 July 2025
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 355% Upside Potential 10 July 2025
Varex Imaging Corporation (VREX) Stock Analysis: A Healthcare Imaging Leader With Nearly 97% Potential Upside 10 July 2025
TotalEnergies SE (TTE) Stock Analysis: A Strong Dividend Play with a 10.96% Upside Potential 10 July 2025
Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 95% Potential Upside in the Medical Device Sector 10 July 2025
Gossamer Bio, Inc. (GOSS) Stock Report: Analysts See a Potential Upside of 459%—Is It Worth the Risk? 10 July 2025
Candel Therapeutics, Inc. (CADL) Stock Analysis: A Promising 261% Upside Potential with Robust Analyst Support 10 July 2025
XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 133% Potential Upside 10 July 2025
NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 67.95% Potential Upside in the Innovative Medical Imaging Sector 10 July 2025
National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a 2.86% Dividend Yield 10 July 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video) 10 September 2025
ZIGUP reports higher underlying revenue and stronger rental performance in HY results 3 December 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield 9 January 2026
WH Smith PLC (SMWH.L) Stock Analysis: Navigating the Retail Landscape with a 19% Upside Potential 9 January 2026
Zigup PLC (ZIG.L) Stock Analysis: Growth Potential with a 26% Upside and Solid Dividend Yield 9 January 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: Strong Technicals Amid Limited Financial Visibility 9 January 2026
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 31.46% Potential Upside with Strong Buy Ratings 9 January 2026
